ARTICLE | Company News
Alza receives approval for Viadur
March 6, 2000 8:00 AM UTC
AZA received approval of its NDA for Viadur leuprolide acetate titanium implant for the palliative treatment of advanced prostate cancer. The company developed Viadur on behalf of Crescendo Pharmaceut...